Skip to Main Content

Paper Details

Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma.
Front Immunol
6
2022
HCC, Hepatocellular Carcinoma, ILC, ILC subsets, ILC1, ILC3, ILC3 cells, ILCS, ILCs, Innate Lymphoid Cells, Innate lymphoid cells, NK-like ILCs, NK-like population, NKp80/, PBMC, PBMCs, PD-1immunotherapy, Patients, anti-CTLA-4, blood, cancer, hepatocellular carcinoma, patients
Author NameAffiliation
Bernd HeinrichCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Bernd HeinrichHannover Medical School
Alexander KroemerMedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital and the Center for Translational Transplant Medicine, Georgetown University Medical Center
Tim F GretenCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Tim F GretenNational Cancer Institute, Center for Cancer Research (NCI CCR) Liver Cancer Program, National Institutes of Health
Firouzeh KorangyCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 6

Datasets

Release 1.2